• Invest
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Product Suite
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Product Suite
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Market Movers
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Commodities
    Currency
    Futures & Options
    Derivatives
    Margin Trading
    Events
    Budget 2024
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Fund Expert
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement

₹ 15000 / 500 shares

IPO Details

RHP/DRHP

Issue Date

05 Nov - 7 Nov'24

Investment/lot

₹ 15000

Price Range

28 - 30

Lot Size

500

IPO Size

₹ 2106.60 Cr

IPO Listing Details

Listing On

12 Nov'24

Issue Price

30

Listed Price

₹ 31.06

Retail Gain/Listing Gain

3.53%

Start date

End date

Allotment of bids

Refund Initiation

Listing on exchange

Sagility India Limited provides technology-enabled business solutions and services to clients in the U.S. healthcare industry. They are a pure-play healthcare focused services provider, and their clients include Payers (U.S. health insurance companies, which finance and reimburse the cost of health services) and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies).

The retail portion of the Saigility India IPO consists of not less than 7,00,29,926 equity shares of face value of ₹10. Not less than 10% of the net offer is for retail individual bidders

Subscription details:

Qualified Institutional Buyer: 75%

Non-Institutional Buyer: 15%

Retail: 10%

The company has a strong order book driven by a clientele that includes a large network od U.S. based hospitals and Payers. By investing in Sagility India Limited IPO, the investor gets to be a part of a company that has an established and diverse clientele.

The company’s financials have shown a steady increase over the last few years. EBITDA has increased from 2105 crores in 2022 to 11,160 crores in FY24, showing a whopping 430% increase and PAT margin has grown from 7.17% in FY22 to 12.40% in FY24. By investing in Sagility India Limited IPO, one can be part of a company that is growing rapidly and one whose finances are in order.

The anchor investor bid opens and ends on Nov 4, 2024. The company may allocate up to 60% of the QIB portion to anchor investors, out of which one third will be allocated to Mutual Funds.

Name of the book running lead managers are

ICICI Securities Limited.

IIFL Securities Limited

Jefferies India Private Limited

J.P. Morgan India Private Limited

Watch and Learn
All you need to know about Sagility India IPO
Particulars As of March 2024 As of March 2023 As of March 2022
Revenue from Operations
47,535.57
42,184.08
9,234.07
Total Equity and Liability
1,06,641.96
1,05,904.76
1,00,962.80
Return on average net worth (%)
3.54%
2.31%
(0.12%)

Presentation of key financial metrics and indicators to assess Sagility India financial health.

Particulars (in Rs. million)

Particulars (in Rs. million)

Particulars (in ₹ Million) As of 31st March, 2024 As of 31st March, 2023 As of 31st March, 2022
Total Income
47,815.04
42,360.60
9,443.94
Profit/(Loss) before tax
2,416.81
1,856.77
(18.54)
Net profit/(loss)
2,404.69
3,764.41
354.92
EPS
0.53
0.33
(0.05)
EBITDA
11,160.37
10,448.64
2,105.72

Leader in the large and resilient U.S. Payer and Provider solutions market

The company has become one of the largest tech-enabled healthcare specialists (by revenue) with coverage across payer and provider markets (Source: Everest Report). Within the healthcare operations outsourced market, they had a share of approximately 1.18% and approximately 1.23% in 2022 and 2023 respectively (Source: Everest Report).

They were ranked as a leader by Avasant in their Clinical Services Business Process Transformation Radar View report 2023 and as a Leader in Everest’s Healthcare Payer Operations PEAK Matrix Assessment 2023 (Source: Everest Report).

Deep, long-term, expanding client relationships across healthcare Payers and Providers

As of January 2024, they served five of the top 10 Payers by enrolment in the U.S. (Source: Everest Report). Their clients also include one of the largest U.S.-based hospital networks in terms of revenue as of January 2024, three of the top 6 PBMs by claims volume (Source: 170 Everest Report), and other large diagnostic laboratories, hospitals, DMEs and radiology companies. As of June 30, 2024, their five largest client groups had an average tenure of 17 years with the Business.

Strong financial performance and high margins

The Business has consistently increased the scope of services provided to clients and the number of clients, leading to growth in revenues in prior periods. Their revenue from operations grew by 9.61% to ₹12,233.28 million for the quarter ended June 30, 2024 from ₹11,160.93 million for the quarter ended June 30, 2023, and by 12.69% to ₹47,535.57 million in Financial Year 2024 from ₹42,184.08 million in FY 2023.

  • Their business is solely focused on the U.S. healthcare industry and may be adversely affected by factors affecting the U.S. healthcare industry, including a decline in the growth of the U.S. healthcare industry, reduction in outsourcing and other trends.

  • The company has in the 12 months preceding the date of this Red Herring Prospectus, issued Equity Shares at a price which may be significantly lower than the Offer Price.

  • One of their Independent Directors has received summons in relation to an ongoing investigation by SEBI of Linde India Limited and the matter is currently pending.

  • Strengthen relationships with existing clients, expand offerings and increase share of their wallets

  • Enhance portfolio of technology tools and platforms

  • Pursue strategic acquisitions and collaborations

Conclusion

Sagility India has been in the leadership position of the industry for some time now. Coupled with that, the company’s comprehensive product range, its skillful workforce and its wide range of clients give it a solid foundation for future growth. If you want to invest in the IPO, ensure you do your homework and assess the risks and challenges thoroughly.

Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO.

Sagility India IPO FAQs

Sagility India IPO will list on 2024-11-12.

2106.60 is the issue size of Sagility India IPO.

The minimum lot size is 500 shares and the investment required is ₹15000.

The price band of Sagility India IPO is ₹28 to ₹30.

You can read more about Sagility India and its IPO from the company’s red herring prospectus (RHP) here.

The Sagility India Limited IPO has an issue size of ₹2106.22 crores. The IPO opens for subscription on 05/11/2024 and closes on 07/11/2024.

Link Intime India Private Limited is the registrar for this IPO.

Open Demat Account to Invest in any IPO
+91 -

personImage
Open Demat Account to Invest in any IPO
+91 -

N
N
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]